Emergent Biosolutions (EBS)Rep. Steve Cohen (TN09) disclosed a sale $1K–$15K
Rep. Steve Cohen (TN09) disclosed a sale of Emergent Biosolutions in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 30 days
- Disclosure lag
- Traded
- Dec 11, 2024
- Disclosed
- Jan 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 11, 2024InsiderDirector sold ~$171K of EBS shares in the open market
- Nov 12, 2024InsiderDirector sold ~$273K of EBS shares in the open market
- Dec 11, 2024 · this disclosureCongressDisclosed sale of EBS — reported range $1,001 - $15,000
What came next
- Mar 12, 2025Insider · 2 peopleInsiders: 2 sales (~$261K)
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Emergent Biosolutions
For Emergent Biosolutions, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EBS page.
Other recent filings by Rep. Steve Cohen (TN09)
- House Clerk periodic transaction report at Fluor (FLR)Jan 26, 2026
- House Clerk periodic transaction report at Northrop Grumman (NOC)Jan 26, 2026
- House Clerk periodic transaction report at Goldman Sachs (GS)Jan 14, 2026
- House Clerk periodic transaction report at Goldman Sachs (GS)Jan 14, 2026
- House Clerk periodic transaction report at Morgan Stanley (MS)Jan 14, 2026
The full history of Rep. Steve Cohen (TN09) is on the profile page.
How this filing works
Other disclosures at Emergent Biosolutions
- SEC Form 144Oct 7, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 5, 2026
- USAspending.gov award recordJun 4, 2026
- USAspending.gov award recordApr 28, 2026
- USAspending.gov award recordMar 4, 2026
Everything OQRO holds on this company is on its EBS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data